✦ LIBER ✦

Anti-infectives: New oral HCV drug shows promise

✍ Scribed by Tse, Man Tsuey

Book ID: 109961095
Publisher: Nature Publishing Group
Year: 2010
Tongue: English
Weight: 186 KB
Volume: 8
Category: Article
ISSN: 1740-1526
DOI: 10.1038/nrmicro2396

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiviral drugs: New oral HCV drug shows

Antiviral drugs: New oral HCV drug shows promise

✍ Tsuey Tse, Man 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 177 KB

New class of HIV drugs shows promise

✍ Dove, Alan 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 49 KB

Docetaxel (TaxotereTM): a new anti-cance

Docetaxel (TaxotereTM): a new anti-cancer drug with promising potential?

✍ Verweij, J 📂 Article 📅 1994 🏛 Nature Publishing Group 🌐 English ⚖ 384 KB

Making a case for inclusion of new oral

Making a case for inclusion of new oral anti-diabetic agents in drug formularies

✍ Wood, M.J. ;Bailey, C.J. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB

New Strategies Combating Bacterial Infec

New Strategies Combating Bacterial Infection || Promising Current Drug Candidates in Clinical Trials and Natural Products Against Multidrug-Resistant Tuberculosis

✍ Ahmad, Iqbal; Aqil, Farrukh 📂 Article 📅 2008 🏛 Wiley-VCH Verlag GmbH & Co. KGaA 🌐 German ⚖ 305 KB 👁 1 views

Combating bacterial infections calls for a multidisciplinary approach and this is what is on offer here. Written by an experienced international team of researchers from various fields ranging from biotechnology to traditional medicine, the book provides complete and comprehensive coverage of topics

Long-term oral treatment of urinary trac

Long-term oral treatment of urinary tract infections with single daily doses of a new antibacterial drug combination (Kelfiprim)

✍ von Niederhäusern, W. ;Boillat, J.-J. ;Petrescu, D. ;Groppi, W. ;Fanfani, A. ;Ma 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 374 KB

Of 30 patients with severe, complicated U.T.I. 27 have been given single daily doses of Kelfiprim (KP), a new sulfatrimethoprim combination, for 8 weeks. In 24 bacteriuria was lastingly controlled, one had a relapse, one had a reinfection, and in one, with bladder carcinoma, bacteriuria persisted. T